Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions

Blood

Volumn 89, Issue 3, 1997, Pages 776-779

  Selvaggi, Thomas A ^a   Walker, Robert E ^a   Fleisher, Thomas A ^a  

^a MSC 1508 ^*

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MONOCLONAL ANTIBODY CD3;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTHUS PHENOMENON; ARTICLE; FETAL CALF SERUM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNODIFFUSION; LYMPHOCYTE CULTURE; LYMPHOCYTE TRANSFER; PRIORITY JOURNAL; TWIN ZYGOSITY;

EID: 0030892087     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.3.776     Document Type: Article

References (20)

1. Masur H Ognibene FR Yarchoan R Shelhamer JH Baird B, Travis W Suffredini AF Deyton L Kovacs JA Falloon J Davey R Polis M Metcalf J Baseler M Wesley R Gill VJ Fauci AS, Lane HC: CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 111:223, 1989
2. Yarchoan R, Venzon DJ, Pluda JM, Lietzau J, Wyvill KM, Tsiatis AA, Steinberg SM Broder S: CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 115:184, 1991
3. Crowe SM Carlin JB Stewart KI Lucas CR Hoy JF: Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 4:770, 1991
4. Fahey JL, Taylor JMG, Detels R Hofmann B Melmed R, Nishanian P Giorgi JV: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 322:166, 1990
5. Anderson WF Blaese RM Culver K: The ADA human gene therapy clinical protocol. Hum Gene Ther 1:331, 1990
6. Aebersold P, Carter CS, Hyatt C, Johnson S, Ottaway K, Leitman SF, Rosenberg SA: A simplified automated procedure for generation of human lymphokine-activated killer cells for use in clinical trials. J Immunol Methods 112:1, 1988
7. Muul LM, Nason-Burchenall K, Carter CS, Cullis H, Slavin D, Hyatt C, Director EP, Leitman SF, Klein HG, Rosenberg SA: Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy. J Immunol Methods 101:171, 1987
8. Lane HC Masur H Longo DL Klein HG Rook AH Quinnan GV Steis RG Macher A Whalen G Edgar LC Fauci AS: Partial immune reconstitution in a patient with the acquired immunodefiency syndrome. N Engl J Med 311:1099, 1984
9. Lane HC Zunich KM Wilson W Cefali F Easter M Kovacs JA Masur H Leitman SF Klein HG Steis RG Longo DL Fauci AS: Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection. Ann Intern Med 113:512, 1990
10. Vilmer E, Rhodes-Feullette A Rabian C Benbunan M Meletis J Devergie A Bourrhis JH Gluckman JC Chermann JC, Gluckman E: Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor. Transplantation 44:25, 1987
11. Hillman GG Haas GP Wahl WH Caallewaert DM: Adoptive immunotherapy of cancer: Biological response modifiers and cytotoxic cell therapy. Biotherapy 5:119, 1992
12. Wilson CC, Wong JT, Girard DD, Merrill DP, Dynan M, An DB, Kalams SA, Johnson RP, Hirsch MS, D'Aquila RT, Walker BD: Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents. J Infect Dis 172:88, 1995
13. Walker R Larson M Carter C Chang L Blaese M Lane HC: Adoptive immunotherapy using activated expanded syngeneic lymphocytes in HIV infected identical twins. Berlin, Germany, IXth International Conference on AIDS in affiliation with the IVth STD World Congress. WS-B28-6:71, 1993 (abstr)
14. Macy E Bulpitt K Champlin RE Saxon A: Anaphylaxis to infusion of autologous bone marrow. An apparent reaction to self, mediated by IgE antibody to bovine serum albumin. J Allergy Clin Immunol 83:871, 1989
15. Lauer SJ, Finlan J, Borella LD, Piaskowski VD, Casper JT: In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum. J Clin Lab Immunol 12:105, 1983
16. Forai G, Green I: Heterologous sera: A target for in vitro cell-mediated cytotoxicity. J Immunol 116:1561, 1976
17. Peck AB, Wigzell H, Janeway C, Andersson LC: Environmental and genetic control of T cell activation in vitro: A study using isolated alloantigen-activated T cell clones. Immunol Rev 35:146, 1977
18. Fogel M Segal S Gorelik E Feldman M: Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum. Int J Cancer 22:329, 1978
19. Reisser D, Michel MF: Fetal bovine serum and immunogenicity of rat colon cancer cells. In Vitro Cell Dev Biol 27A:521, 1991 (letter)
20. Irie RF, Irie K, Morton DL: Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. J Natl Cancer Inst 52:1051, 1974